SMAD2 and cancer: TIPE2, a member of the same family, suppresses OVCA metastasis and epithelial–mesenchymal transition by interacting with SMAD2, indicating that our findings need to be experimentally validated for the role of TIPE3 in promoting cancer (Tang et al., 2024).